Cholangiocarcinoma: what are the most valuable therapeutic targets – cancer-associated fibroblasts, immune cells, or beyond T cells?
.
Source: Expert Opinion on Therapeutic Targets - Category: Drugs & Pharmacology Authors: Juan Wang Emilien Loeuillard Gregory J. Gores Sumera I. Ilyas Source Type: research
More News: Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Drugs & Pharmacology